A shadow market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Investigational Treatment Acquiring Popularity Via Social Media
The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed fat-burning properties. Followers are encouraged to contact these profiles privately for supplier links, while also receiving discount codes.
Active Trade on Social Networks
Additionally, a robust trade exists on messaging services, where communities with thousands of members share “before and after” images, administration instructions and claims of rapid British shipping. Sellers market the substance there before directing buyers to WhatsApp for purchases.
Learning About Retatrutide
Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.
Medical Professionals Voice Concerns
However, doctors and pharmacists have warned that the sale of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to users injecting products of uncertain source.
Some experts stated the popularity for the experimental drug could be connected to the rising cost of approved weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the British medical regulations.
Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach pharmaceutical, marketing, and customer regulations, potentially leading to fines, prosecution or prison.
Platform Response and Material Removal
According to TikTok, the service has taken down problematic content and banned associated keywords and query recommendations. The organization stated it was committed to maintaining the platform secure and investing in strengthening compliance measures.
Online Trading Activities
Investigations also found groups with up to 9,000 members selling retatrutide using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, populated with photos of weight loss, positive reviews and step-by-step instructions for mixing or administering at residence.
After minutes of joining one group, a seller shared contact information, where most transactions take place. The seller sent an instruction manual and promised delivery within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about weight, medical conditions or previous experience.
Product Information and Pricing
Inside these communities, messages display dark colored parcels with postal service labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When questioned how much time a pen should last, sellers give conflicting answers varying between a several days to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for the messaging service stated it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are administering substances they can’t verify. Even if the science behind retatrutide is sound, these online products may not include what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are turning to social media. But fake treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.
Her staff has already seen patients injured by self-injection from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”
Producer Statement
A representative from Eli Lilly said the substance was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company investigational substance not yet approved … may expose users to possibly serious health risks”.
